Avidity Biosciences, Inc. — Director's Dealing 2020

Dec 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-12-22

Reporting Person: WILSON TROY EDWARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-22	Common Stock	J	100000	$0.00	Disposed	89618	Direct
2020-12-22	Common Stock	J	100000	$0.00	Acquired	100000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	805301	Indirect
Common Stock	35553	Indirect
Common Stock	35553	Indirect
Common Stock	11851	Indirect
Common Stock	11851	Indirect

Footnotes

F1: Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family.